Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Cancer research, Lung cancer, KEAP1, Downregulation and upregulation, Oxidative stress, and Regulator.
Cooperative nutrient scavenging is an evolutionary advantage in cancer
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors